Karolinska Institutet
-
healthStockholm3 Blood Test Detects 90% of Aggressive Prostate Cancer, Outperforming PSA Screening
A new blood test, Stockholm3, identifies aggressive prostate cancer with 90% accuracy in trials, significantly improving upon the standard PSA test and potentially reducing unnecessary procedures.
-
healthSmartphone Monitoring Slashes Cardioversion Cancellations in Swedish Trial
A new Swedish study reveals that pre-procedure smartphone heart monitoring significantly reduces same-day cardioversion cancellations, optimizing healthcare resources and patient care.
-
healthSweden Markets Itself as a Doctor-Prescribed Wellness Destination
Sweden's new campaign positions the country as a first destination to be prescribed by doctors for mental and physical health.
-
healthMeat Consumption and Dementia Risk: A Gene-Specific Link Emerges
New research suggests a complex relationship between meat intake and dementia risk, particularly for individuals with the APOE4 gene variant. The study highlights potential dietary nuances for cognitive health.
-
healthWeight-Loss Drug Semaglutide Linked to Lower Mental Health Risks
New study shows semaglutide significantly reduces risks of depression, anxiety, and self-harm in patients with obesity or diabetes.
-
healthProstate Cancer Screening Shows Minimal Impact on Quality of Life
New EAU 2026 data reveals prostate cancer screening has modest effects on men's quality of life and anxiety, informing future health policy.